Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 1003.00 | 1926.00 | 0.5208 | 0.1091 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 1250.00 | 894.42 | 771.00 | 1926.00 | 0.4003 | -0.1256 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1911.00 | 1926.00 | 0.9922 | 0.9859 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1824.00 | 1926.00 | 0.9470 | 0.9040 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1563.00 | 1926.00 | 0.8115 | 0.6560 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1637.00 | 1926.00 | 0.8500 | 0.7267 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 1250.00 | 894.42 | 1848.00 | 1926.00 | 0.9595 | 0.9267 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 1689.00 | 1926.00 | 0.8770 | 0.7762 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1982.00 | 1926.00 | 1.0291 | 1.0525 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 1250.00 | 894.42 | 1156.00 | 1926.00 | 0.6002 | 0.2609 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 2108.00 | 1926.00 | 1.0945 | 1.1700 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 1250.00 | 894.42 | 1014.00 | 1926.00 | 0.5265 | 0.1201 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 1625.00 | 1926.00 | 0.8437 | 0.7153 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 1250.00 | 894.42 | 1822.00 | 1926.00 | 0.9460 | 0.9022 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 1691.00 | 1926.00 | 0.8780 | 0.7781 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 2205.00 | 1926.00 | 1.1449 | 1.2601 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 1250.00 | 894.42 | 2012.00 | 1926.00 | 1.0447 | 1.0805 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 1250.00 | 894.42 | 1224.00 | 1926.00 | 0.6355 | 0.3278 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 1250.00 | 894.42 | 1470.00 | 1926.00 | 0.7632 | 0.5667 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2077.00 | 1926.00 | 1.0784 | 1.1412 | |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 1250.00 | 894.42 | 858.00 | 1926.00 | 0.4455 | -0.0369 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 1250.00 | 894.42 | 688.00 | 1926.00 | 0.3572 | -0.2111 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 1848.00 | 1926.00 | 0.9595 | 0.9267 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 2165.00 | 1926.00 | 1.1241 | 1.2230 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 1369.00 | 1926.00 | 0.7108 | 0.4691 |